This webinar summarises recent empirical work investigating the ability of users of hand-held devices to complete longer injection times effectively. The study provides insights into the effects of injection duration on the force exerted by the user to hold the device against the injection site. It also highlights whether and how the characteristics of patient groups affect their ability to withstand longer injection duration, and considers the upper feasible limit of injection duration.
Andreas Schneider, PhD, is Innovation & Business Development Director at Ypsomed Delivery Systems. He leads a team that drives the definition and development of new drug delivery device platforms, such as next-generation pen and autoinjector devices, wearable patch injectors, connected systems and digital solutions.
Christoph Jordi is Director of Usability & Human Factors at Ypsomed. He leads a team that is responsible for user-centered research and design activities as well as standard-compliant Human Factors Engineering.
Philippe Müller, is Innovation & Business Development Manager at Ypsomed Delivery Systems. He drives device and business model innovation projects with special focus on connected devices and digital solutions.